Assistant Professor of Cell and Developmental Biology Dirk Hockemeyer has received an American Association of Anatomists Young Investigator Award for his contributions to the field of developmental biology.
Below are articles from various sources about members of MCB and their research.
New research out of the Raulet lab suggests a mechanism explaining why Natural Killer cells are sometimes rendered ineffective, and even more excitingly, suggests a therapeutic approach for re-awakening them to attack tumors.
A newly announced biotech deal shows how basic research at UC Berkeley is leading to new therapeutic approaches for cancer.
Class of '33 Chair and Professor of Neurobiology, Ehud Isacoff, who also holds an appointment with Lawrence Berkeley Lab, and who directs the Helen Wills Neuroscience Institute, conducted a study of translucent zebrafish embryos that could lead to powerful new tools in neuroscience.
Howard Hughes Investigator and Professor of Genetics, Genomics and Development Nicole King will receive an honorary Doctor of Science from Lehigh University during the university’s 147th commencement ceremony on May 18.
Professor Jennifer Doudna and other leading bioligists authored an article calling for a worldwide moratorium on the use of her new genome-editing technique until scientists, ethicists and the public fully understand the issues surrounding the breakthrough.
Professors Jennifer Doudna (MCB) and Montgomery Slatkin (IB), were chosen for their distinguished research excellence by the Academic Senate, and will present public lectures as part of the Martin Meyerson Faculty Research Lectures. Since 1912, these events have offered an opportunity to hear from the people who are transforming knowledge at Berkeley and in our world.
Associate Professor of Neurobiology and member of the Helen Wills Neuroscience Institute Dan Feldman has received a UC Berkeley Distinguished Teaching Award.
Feldman will be honored at a ceremony on April 21st, at 5pm, in the Zellerbach Playhouse. This ceremony is open to the public.
Assistant Professor of Biochemistry, Biophysics and Structural Biology and Bakar Fellow Andreas Martin is launching a search for small-molecule drugs to block the ability of cancer cells to rid themselves of proteins. Doing so would overwhelm the cells with excess baggage and kill them. A successful drug would also expose cancer cells to tumor-suppressor proteins, which prevent rampant division.
Watch the video: Jennifer Doudna and Lance Knobel have a discussion at the UnCharted 2014 Festival of Ideas.